Showing results (731-740 of 1,838) with videos related to

Sort By:
Pageof 184
ESMO Open|January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trialF Piscaglia, G Masi, E Martinelli, et al.
ESMO Open|January 28, 2025
An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterationsK H Kim, C Park, S-H Beom, et al.
ESMO Open|February 5, 2025
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
ESMO Open|January 22, 2025
Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORAL H Douma, M M Hofman, F Zwierenga, et al.
ESMO Open|November 14, 2024
Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insightsV Tuninetti, J A Marín-Jiménez, G Valabrega, et al.
ESMO Open|November 19, 2024
A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohortG Roth, A Pellat, G Piessen, et al.
ESMO Open|November 30, 2024
Measuring financial distress in German cancer patients: development and validation of the Financial Distress of Cancer Assessment Tool (FIAT)L Richter, S Pauge, K Mehlis, et al.
ESMO Open|November 22, 2024
Collagen signature adds prognostically significant information to staging for breast cancerZ Li, D Kang, S Xu, et al.
ESMO Open|November 30, 2024
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancerS-H Lee, J Menis, T M Kim, et al.
ESMO Open|March 8, 2025
Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparisonM Diefenhardt, R Kosmala, M Fleischmann, et al.
Pageof 184